Managed Healthcare Executive® State of the Industry Survey Results, Part 1
Respondents ranked labor shortages and closing healthcare disparities the highest when asked what about most important issues facing U.S. healthcare in 2023.
What issues and challenges in healthcare will loom the largest this year?
That was question we asked in our annual State of the Industry this year. Respondents rated issues on a scale of 1-10 with 10 being the most important. We then weighted the answers with 10 having a value of 10, 9 having a value of 9, and so on.
The results were close but labor shortages ranked the highest in importance (weighted score of 6.73), followed by closing healthcare disparities (6.69) and long covid (6.63).
Adoption of the biosimilars (6.37) and interoperability (6.27) came out at the bottom of the importance ranking.
It is not surprising that labor shortages topped the list. The news has been full of stories about staffing shortages and related labor unrest. The U.S. Bureau of Labor Statistics has projected that there will be 200,000 openings for registered nurses each year over the next eight years. The bureau says employment of nurses is expected to grow by 6% in the 2020s, but that is about the same rate of growth as other occupations. The openings are the result of retirements and people leaving nursing for other professions.
The MHE State of the Survey was conducted in late November and early December 2022. Our colleagues at Medical Economics® helped disseminate the survey. The survey had just over 450 respondents.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More
